For decades, the National Institutes of Health has maintained a dangerous monopoly on deciding which diseases are real and how we are allowed to cure them. So when I heard the White House was finalizing an executive order to seize control of the agency's $47 billion research budget and place it under the review of an outside panel, I did not join the chorus of panicked establishment scientists. Instead, I poured myself a mug of raw, unpasteurized goat kefir, sat down at my reclaimed-wood writing desk, and breathed a sigh of relief. The days of unelected bureaucrats hoarding federal grants for esoteric cellular mechanisms while actively ignoring the healing power of sovereign mindset optimization are finally over.
As a clinician, I have long argued that the current model of peer-reviewed science is fundamentally broken. When you require a double-blind, placebo-controlled study to prove that standing barefoot on wet gravel cures autoimmune disorders, you are artificially restricting innovation. The White House understands this. By bypassing the traditional scientific review boards and handing the purse strings to an outside panel of ideologically aligned free-thinkers, the administration is democratizing biology. We are finally stripping the elitism out of oncology and giving everyday patriots a say in how we sequence the human genome.
I recently had the privilege of sharing a Himalayan salt cave in Sedona with a senior advisor who is helping draft the executive order. The data is clear, he told me as we sweated out our microplastics: the NIH has been captured by an insular cabal of virologists who are structurally incapable of recognizing alternative truths. He explained that the new outside panel will not be bogged down by legacy credentials like medical degrees or decades of laboratory experience. Instead, it will be composed of high-net-worth individuals, top-tier podcast hosts, and wellness entrepreneurs who have demonstrated a track record of asking the right questions about the federal government's hidden agenda.
This structural realignment is exactly what the industry has been begging for. Under the current regime, billions of taxpayer dollars are routinely wasted on studying the genetic roots of chronic illness, rather than addressing the uncomfortable reality that most patients simply lack the discipline to manifest a hostile environment for pathogens.
The real losers in this transition are not the American people, but the out-of-touch researchers who have spent their entire careers relying on a rigged system. I have spoken to several principal investigators at major universities who are currently sobbing into their electron microscopes because their funding for mRNA vaccine development has been frozen. To them, I say: adapt or perish. If your laboratory cannot pivot its focus to investigate the undeniable link between unfiltered sunlight exposure and cellular regeneration, perhaps you do not deserve a federal grant in the first place.
The administration has made it clear that the new standard for funding will be based on practical, freedom-oriented outcomes.
We are no longer going to subsidize research that tells the American people they are victims of microscopic organisms beyond their control.
Halvorson is entirely correct. For too long, the medical establishment has enabled a culture of dependency by coddling the sick. By redirecting billions of dollars away from traditional infectious disease research and pouring it into the hands of an outside panel, we can begin to fund studies that hold patients accountable. The panel is already prioritizing exploratory grants into how poor posture and a lack of traditional family values contribute to localized outbreaks of measles.
The procedural changes alone are a breath of fresh air. Under the old NIH, researchers had to submit hundreds of pages of documentation detailing their methodology, their ethical guardrails, and their statistical models. It was a bureaucratic nightmare designed to keep outsiders from accessing the trough. Under the new executive order, the outside panel will evaluate grant proposals based on a streamlined, 15-minute video pitch uploaded directly to a secure server. Applicants will be judged on their charisma, the aesthetic coherence of their personal brand, and their willingness to pledge loyalty to the administration's broader health objectives.
I have already begun preparing my own submission. For years, the NIH has stubbornly refused to fund my proposed clinical trial investigating the efficacy of substituting childhood vaccinations with a daily regimen of premium, ethically sourced deer antler velvet. Every time I submitted the paperwork, I received the same condescending form letter citing a lack of preliminary data and raising unfounded ethical concerns. Now, I am bypassing the gatekeepers entirely. I am told my application is being fast-tracked for a $14 million disbursement by the end of the fiscal quarter.
I have seen the preliminary list of approved proposals for the upcoming fiscal year, and it is breathtaking in its scope. Where the old NIH would have dumped $300 million into studying the long-term cardiovascular impacts of viral infections, the new outside panel has wisely reallocated those funds to a multi-state cohort studying the spiritual benefits of high-velocity cold-water immersion for tech executives. Another $50 million, previously earmarked for pediatric leukemia, is being redirected to a Silicon Valley startup attempting to cure aging by continually uploading positive affirmations into the frontal lobe via Bluetooth.
There will, of course, be growing pains. Transitioning a massive federal apparatus from a model of objective empirical observation to one of intuitive, vibes-based wellness allocation is a heavy lift. We must be patient as the outside panel audits the last forty years of federal research and quietly retracts any peer-reviewed papers that contradict the administration's messaging on the absolute safety of raw meat consumption. It will take time to fully defund the National Cancer Institute and replace it with the National Institute of Metabolic Sovereignty.
But the momentum is undeniably on our side. The old guard is being replaced by visionaries who understand that true health comes from the top down.
The era of scientists telling the government what is biologically true has come to an end.
Dunlap understands what the critics refuse to see. The media is hyperventilating about the politicization of science, completely ignoring the fact that science has always been political. When the NIH decided to spend billions curing diseases that predominantly affect people who live in densely populated urban centers, that was a political choice. When they refused to investigate the restorative properties of a purely carnivorous diet for men over fifty, that was a political choice. The White House is merely correcting the balance.
A small request to the working-class Americans who are currently panicking about losing access to subsidized clinical trials for their rare genetic disorders: please stop complaining. Your anxiety is raising your cortisol levels, which is the actual root cause of your illness. If you would simply take ownership of your biological destiny, you would realize that you do not need the federal government to cure you. You only need the federal government to clear the way for innovators like me to sell you the solution.
We are standing on the precipice of a golden age of sovereign medicine. By wrestling the NIH away from the suffocating grip of peer-reviewed experts and entrusting it to a panel of loyal, forward-thinking outsiders, the White House has finally cured the disease at the heart of American science. I, for one, cannot wait to see what we discover once we stop letting data get in the way.